Picture of Biorestorative Therapies logo

BRTX — Biorestorative Therapies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: BioRestorative Therapies Hosts Principal Investigator Meeting for BRTX-100 Trial

April 29 (Reuters) - BioRestorative Therapies Inc  BRTX.O :
    * BIORESTORATIVE THERAPIES HOSTS PRINCIPAL INVESTIGATOR
MEETING
FOR ITS BRTX-100® PHASE 2 CLINICAL TRIAL TO TREAT CHRONIC LUMBAR
DISC DISEASE

Source text for Eikon:  ID:nGNX4HsTw 
Further company coverage:  BRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Biorestorative Therapies

See all news